TD Asset Management
AUPH icon

TD Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

TD Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-315,979
Closed -$4.24M – 1527
2021
Q2 		$4.24M Sell
315,979
-64,480
-17% -$821K ﹤0.01% 873
2021
Q1 		$4.95M Sell
380,459
-153,768
-29% -$2.23M 0.01% 828
2020
Q4 		$7.36M Buy
534,227
+64,964
+14% +$945K 0.01% 685
2020
Q3 		$6.89M Buy
469,263
+30,536
+7% +$442K 0.01% 629
2020
Q2 		$7.1M Buy
438,727
+260,631
+146% +$4.17M 0.01% 584
2020
Q1 		$2.56M Buy
+178,096
New +$3.14M ﹤0.01% 771
2017
Q2 		– Sell
-32,887
Closed -$241K – 1337
2017
Q1 		$241K Buy
+32,887
New +$152K ﹤0.01% 1351

Other funds holding AUPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

TD Asset Management's AUPH Position: Q3 2021 in Review

TD Asset Management sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2021, closing a stake of 315,979 shares — an estimated $4.24M sold.

TD Asset Management first reported a position in AUPH in Q1 2017 and held it in 7 quarters. The position peaked at $7.36M in Q4 2020. 166 funds tracked by Wall St. Rank hold AUPH as of Q3 2021.

  • TD Asset Management reported no remaining Aurinia Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • TD Asset Management sold 315,979 Aurinia Pharmaceuticals shares in Q3 2021, an estimated $4.24M.
  • TD Asset Management first reported a position in Aurinia Pharmaceuticals in Q1 2017 and held it in 7 quarters.
  • TD Asset Management's Aurinia Pharmaceuticals position peaked at $7.36M in Q4 2020.
  • 166 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2021.

Based on TD Asset Management's 13F filing for Q3 2021, filed 9 Nov 2021.